No Data
Apeloa Pharmaceutical (000739.SZ): has not yet repurchased the company's shares.
On March 3, Gelonghui reported that Apeloa Pharmaceutical (000739.SZ) announced that as of February 28, 2025, the company has not yet repurchased its shares through the repurchase special Account via centralized bidding Trade.
China Merchants: The surge in ADC research and development is driving a significant increase in outsourcing demand, and the ADC CDMO market is thriving.
The surge in ADC research and development has driven a significant increase in outsourcing demand, with strong market demand for ADC CDMO. Currently, the market shows a dual drive of capacity expansion and technological iteration.
Apeloa Pharmaceutical Plans Share Buyback of Up to 150 Million Yuan
Apeloa Pharmaceutical Co.,Ltd's (SZSE:000739) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
Apeloa Pharmaceutical (000739.SZ): Has not yet started the research and development of oral formulations of Semaglutide.
Glonghui, January 20 - Apeloa Pharmaceutical (000739.SZ) stated on the investor interaction platform that, so far, the company has not started the research and development of oral formulations of semaglutide.
Apeloa Pharmaceutical (000739.SZ): Currently not involved in utilizing AI Q&A training to assist in the Medical Services related fields.
On January 17, Gelonghui reported that Apeloa Pharmaceutical (000739.SZ) stated on the investor interaction platform that currently, the company's exploration and application of AI technology mainly focus on pharmaceutical manufacturing and Operation management, assisting in the improvement of the company's manufacturing automation, digitization level, and operational efficiency; it does not currently involve the use of AI question-and-answer training to assist in the field of Medical Services.
Is Apeloa Pharmaceutical Co.,Ltd's (SZSE:000739) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?
